EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasmacytic markers as immunotherapeutic targets for primary CD20 ‐negative aggressive B‐cell lymphomas

Frank Neumann, Claudia Schormann, Onur Cetin iD, Igor A Kos iD, Moritz Bewarder iD, Eva C Schwarz iD, Stefan Lohse, Stephanie Maurer, Philipp B Staber, Joerg T Bittenbring, Sigrun Smola, Konstantinos Christofyllakis und 2 weitere

British Journal of Haematology · 2026-07 · 209 (1) · 300-305

DOI: 10.1111/bjh.70557 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 21.05.2026. Verfasst von Frank Neumann und 13 weiteren Autor:innen. Beteiligte Einrichtung: José Carreras Center for Immuno- and Gene Therapy and Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dr. Rolf M. Schwiete Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ADCCBCMACD19CD20CD38CD79bSLAMF7primary CD20‐negative aggressive B‐NHL

Autor:innen und Institutionen

  • José Carreras Center for Immuno- and Gene Therapy and Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany.
  • Department of Oncology, Bethanien Hospital, Frankfurt am Main, Germany.
  • Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, Germany.
  • Institute of Virology, Saarland University, Homburg, Germany.

ORCID-Profile: Onur Cetin, Igor A Kos, Moritz Bewarder, Eva C Schwarz, Lorenz Thurner

Förderung

  • Dr. Rolf M. Schwiete Stiftung

Zitieren

APA

Neumann, F., Schormann, C., Cetin, O., Kos, I. A., Bewarder, M., Schwarz, E. C., Lohse, S., Maurer, S., Staber, P. B., Bittenbring, J. T., Smola, S., Christofyllakis, K., Hoth, M., & Thurner, L. (2026). Plasmacytic markers as immunotherapeutic targets for primary CD20 ‐negative aggressive B‐cell lymphomas. British Journal of Haematology, 209(1), 300-305. https://doi.org/10.1111/bjh.70557

Vancouver

Neumann F, Schormann C, Cetin O, Kos IA, Bewarder M, Schwarz EC, et al. Plasmacytic markers as immunotherapeutic targets for primary CD20 ‐negative aggressive B‐cell lymphomas. British Journal of Haematology. 2026;209(1):300-305. doi:10.1111/bjh.70557

BibTeX
@article{Neumann2026,
  author = {Neumann, Frank and Schormann, Claudia and Cetin, Onur and Kos, Igor A and Bewarder, Moritz and Schwarz, Eva C and Lohse, Stefan and Maurer, Stephanie and Staber, Philipp B and Bittenbring, Joerg T and Smola, Sigrun and Christofyllakis, Konstantinos and Hoth, Markus and Thurner, Lorenz},
  title = {Plasmacytic markers as immunotherapeutic targets for primary CD20 ‐negative aggressive B‐cell lymphomas},
  journal = {British Journal of Haematology},
  year = {2026},
  volume = {209},
  number = {1},
  pages = {300--305},
  doi = {10.1111/bjh.70557}
}
Kostenlos starten →